Arianna Vignini Selected Research

Asthenozoospermia

6/2015	Protective effects of coenzyme Q10 and aspartic acid on oxidative stress and DNA damage in subjects affected by idiopathic asthenozoospermia.
11/2014	Interleukin-1β, cyclooxygenase-2, and hypoxia-inducible factor-1α in asthenozoospermia.
3/2013	Involvement of sperm plasma membrane and cytoskeletal proteins in human male infertility.
3/2012	Nitric oxide synthase and tyrosine nitration in idiopathic asthenozoospermia: an immunohistochemical study.
9/2010	Single nucleotide polymorphism (SNP) of the endothelial nitric oxide synthase (eNOS) gene (Glu298Asp variant) in infertile men with asthenozoospermia.
5/2009	Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arianna Vignini Research Topics

Disease

7	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 04/2003
6	Asthenozoospermia 06/2015 - 05/2009
5	Hypertension (High Blood Pressure) 01/2016 - 04/2003
3	Insulin Resistance 06/2022 - 10/2008
3	Autism Spectrum Disorder 01/2022 - 01/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 01/2003
3	Diabetes Mellitus 04/2020 - 11/2002
3	Type 2 Diabetes Mellitus (MODY) 04/2020 - 10/2008
3	Obesity 12/2019 - 10/2008
3	Anorexia Nervosa 06/2019 - 01/2008
3	Inflammation (Inflammations) 12/2017 - 01/2009
3	Ischemic Stroke 12/2011 - 09/2007
2	Overweight 04/2022 - 08/2019
2	Neoplasms (Cancer) 02/2021 - 03/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 05/2017
2	Atherosclerosis 10/2017 - 11/2002
2	Leiomyoma (Uterine Fibroids) 10/2017 - 12/2016
2	Hypoxia (Hypoxemia) 01/2017 - 11/2014
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2016 - 01/2012
2	Stroke (Strokes) 04/2008 - 09/2007
1	Multiple Sclerosis 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Autistic Disorder (Autism) 01/2022
1	Amyloid Plaque 12/2021
1	Breast Neoplasms (Breast Cancer) 02/2021
1	Malnutrition (Nutritional Deficiencies) 03/2020
1	Anorexia 06/2019
1	Hyperglycemia 01/2019
1	Hypercholesterolemia 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Brain Diseases (Brain Disorder) 10/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2017
1	Critical Illness (Critically Ill) 01/2017
1	Hyperoxia 01/2017
1	Premature Obstetric Labor (Premature Labor) 03/2015
1	Cognitive Dysfunction 12/2013
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 12/2013
1	Male Infertility (Male Sterility) 03/2013

Drug/Important Bio-Agent (IBA)

11	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2017 - 01/2005
5	AntioxidantsIBA 08/2019 - 09/2007
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2011
4	Insulin (Novolin)FDA Link 01/2019 - 01/2005
4	Peroxynitrous Acid (Peroxynitrite)IBA 01/2012 - 09/2007
3	Platelet Activating FactorIBA 01/2022 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2013
3	EnzymesIBA 01/2022 - 09/2011
3	Aryldialkylphosphatase (Paraoxonase)IBA 08/2019 - 01/2015
3	coenzyme Q10 (CoQ10)IBA 08/2019 - 05/2009
3	Adenosine Triphosphatases (ATPase)IBA 10/2018 - 04/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2017 - 09/2007
3	Lipoproteins (Lipoprotein)IBA 01/2015 - 01/2008
2	Glutathione (Reduced Glutathione)IBA 01/2022 - 01/2017
2	Calcitonin Gene-Related PeptideIBA 01/2022 - 12/2021
2	3-nitrotyrosineIBA 12/2019 - 09/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 01/2011
2	Lipid PeroxidesIBA 08/2019 - 12/2011
2	CholesterolIBA 10/2017 - 01/2008
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2016 - 09/2011
2	Pharmaceutical PreparationsIBA 03/2015 - 04/2003
2	HydrolasesIBA 01/2015 - 01/2015
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2015 - 01/2015
2	oxidized low density lipoproteinIBA 01/2015 - 11/2002
2	Amyloid (Amyloid Fibrils)IBA 12/2013 - 05/2013
2	Nitric Oxide Synthase (NO Synthase)IBA 03/2012 - 01/2011
2	CopperIBA 11/2003 - 01/2003
1	Indicators and Reagents (Reagents)IBA 06/2022
1	CarbohydratesIBA 06/2022
1	DNA (Deoxyribonucleic Acid)IBA 04/2022
1	Arthropod VenomsIBA 01/2022
1	Islet Amyloid PolypeptideIBA 12/2021
1	NeuropeptidesIBA 12/2021
1	Peptides (Polypeptides)IBA 12/2021
1	AcidsIBA 02/2021
1	SugarsIBA 04/2020
1	Proprotein Convertase 9IBA 01/2019
1	Atrial Natriuretic Factor (ANF)IBA 01/2019
1	LDL Receptors (LDL Receptor)IBA 01/2019
1	PotassiumIBA 10/2018
1	SodiumIBA 10/2018
1	CytokinesIBA 12/2017
1	LipidsIBA 10/2017
1	Erythropoietin FDA Link 01/2017
1	Oxygen (Dioxygen)IBA 01/2017
1	Vitamin D FDA LinkGeneric 12/2016
1	Aspartic Acid (Aspartate)FDA Link 06/2015
1	Oxytocin Receptors (Oxytocin Receptor)IBA 03/2015
1	Oxytocin (Pitocin)FDA LinkGeneric 03/2015
1	atosibanIBA 03/2015
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2014
1	Messenger RNA (mRNA)IBA 12/2013
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 12/2013
1	Amyloid beta-PeptidesIBA 12/2013
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 12/2013
1	Cytoskeletal ProteinsIBA 03/2013
1	TetraspaninsIBA 03/2013
1	ezrinIBA 03/2013
1	Tyrosine (L-Tyrosine)FDA Link 03/2012

Therapy/Procedure

4	Therapeutics 01/2019 - 09/2007
2	Drug Therapy (Chemotherapy) 02/2021 - 03/2020
1	Glycemic Control 04/2020